MyPatientPal: An App to Help Patients Manage Their Cancer Care

Felicity Harper

Status: Completed

Conditions: Cancer

Treatments: Other: MyPatientPal smartphone app

Study type: Interventional

Funder types: Other

Identifiers

NCT03684005

2018-063

Details and patient eligibility

About

MyPatientPal was developed in collaboration with both patient and oncologist stakeholders, is designed to facilitate such patient self-management through the daily reporting of side effects and medications.

Full description

MyPatientPal is a patient app that is designed to help patients track and manage treatment side effects and medication adherence on a daily basis. Side effects (e.g., pain, fatigue, diarrhea, nausea) can be physically and emotionally debilitating, and when uncontrolled, can cause treatment complications, resulting in unscheduled care costs, patient out-of-pocket costs, and delays or discontinuation of treatment. The app allows personalization of daily entries such that patients can select the specific medications and dosage and side effects (using items from the NCI Common Terminology Criteria for Adverse Events) that they and/or their providers want to track. A charting feature provides an easy-to-read display of patients' daily reports, summarizing the intensity and frequency of side effects and medication use either by week or by month. These reports can also be printed out and shared with providers.

Enrollment: 40 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have a diagnosis of any solid tumor cancer
• Be starting treatment using an oral cancer therapeutic agent
• Be able to speak, read, and write English
• Willing and able to use their smartphone to use MyPatientPal

Exclusion criteria

• Patients with cognitive or perceptual disturbances

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40 participants in 1 patient group

Single-Arm Smartphone App Use

Other group

Description:

All patients in this single-arm study will use a smartphone-based app, MyPatientPal, to enter symptoms and track medications related to their cancer treatment. No drugs will be administered for the purposes of this behavioral study.

Treatment:

Other: MyPatientPal smartphone app